Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
{4-[(2S)-2-Acetamido-3-({(1S)-1-[3-carbamoyl-4-(cyclohexylmethoxy)phenyl]ethyl}amino)-3-oxopropyl]-2-phosphonophenoxy}acetic acid
- Development stage
- Unknown
- Modality
- Small Molecules
01
Overview
This compound is a synthetic small molecule belonging to the class of phenylalanine derivatives. It has not been approved for use in any country and is classified as experimental. There are no known clinical indications or marketed formulations. Its structure features an acetamido group, a carbamoyl-cyclohexymethoxy-substituted phenylethylene moiety, and a phosphono group attached to a phenoxyacetic acid backbone. No detailed mechanism of action or biological target has been established in the literature or major drug databases[1][2][6]. The compound appears in chemical and patent literature as part of research into novel carbamoylglycine derivatives but lacks further pharmacological characterization.
- Other names
- Acetic acid, 2-[4-[(2S)-2-(acetylamino)-3-[[(1S)-1-[3-(aminocarbonyl)-4-(cyclohexylmethoxy)phenyl]ethyl]amino]-3-oxopropyl]-2-phosphonophenoxy]Acide {4-[(2S)-2-acétamido-3-{(1S)-1-[3-carbamoyl-4-(cyclohexylméthoxy)phényl]éthyl}amino}-3 oxopropyle}- 2-phosphonophénoxy}acétique(4-{2-Acetylamino - [ChemSpider][ACD/IUPAC Name]]
Beyond the preview
Go deeper on {4-[(2S)-2-Acetamido-3-({(1S)-1-[3-carbamoyl-4-(cyclohexylmethoxy)phenyl]ethyl}amino)-3-oxopropyl]-2-phosphonophenoxy}acetic acid.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on {4-[(2S)-2-Acetamido-3-({(1S)-1-[3-carbamoyl-4-(cyclohexylmethoxy)phenyl]ethyl}amino)-3-oxopropyl]-2-phosphonophenoxy}acetic acid.